Encrypted | Login

Report No. 135 - Liver Cancer Risk from Internally-Deposited Radionuclides (2001)

Price: $20 / $16 PDF (AAPM Members FREE)
Category: Reports

Report No. 135 (2001) updates the liver cancer risk of Thorotrast in humans. Thorotrast, a radiographic contrast medium containing naturally occurring radionuclides of thorium was widely used in the first half of the twentieth century. An increased incidence of liver cancer in this population of patients has been known for some time. Utilizing data on the liver cancer risk of Thorotrast and of low-LET radiations in animals, the liver cancer risk of low-LET radiation in humans is also estimated.
Scientific Committee:
Antone L. Brooks, Co-Chairman
Glenn N. Taylor, Co-Chairman

Steve Benjamin
G. van Kaick
Kurt Wegener
Horst Wesch
DISCLAIMER
I Disagree
I Agree

Show list of all NCRP documents »